期刊文献+

阴茎Peyronie病动物模型研究进展 被引量:2

Animal models of Peyronie's disease: An update
下载PDF
导出
摘要 Peyronie病以阴茎白膜局部纤维斑块形成为特征,在临床中相对少见。国内外与之相关的基础研究甚少,除疾病本身相对少见外,可能与疾病动物模型的不确定性有一定关系。目前较常用的Peyronie病动物模型各存利弊,其中转化生长因子β1(TGF-β1)与Fibrin白膜下注射缺乏阴茎弯曲、钙/骨化等特征;手术创伤可能建立Peyronie病急性期模型;自发模型则可能带来全身多组织器官纤维化与人Peyronie病表现不一等不足。模型的选择对基础研究至关重要,因此,本文通过回顾Peyronie病相关的动物研究模型,为该病基础研究提供参考。 Peyronie's disease is characterized by local fibrosis of the tunica albuginea and relatively rare clinically. Few relevant basic researches could be retrieved,which might be attributed to the absence of a robust animal model of the disease as well as to its rareness. At present,some animal models available for Peyronie's disease have their own merits and demerits. TGF-β1-induced and Fibrin-induced models are lack of penile curvature and calcification / ossification. A surgical model might be established for the acute phase of the disease. The characteristic of a widespread fibrotic process involving many organs in the spontaneous model is quite different from that of human Peyronie's disease. Therefore,choosing the right model is essential for researches. This paper presents an overview of the animal models of Peyronie's disease,meant to provide some reference for the basic research of the disease.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2016年第5期446-449,共4页 National Journal of Andrology
基金 国家自然科学基金(81270691 81770565) 四川省国际合作计划(2013HH0008) 四川省科技支撑计划(2012SZ0151)~~
关键词 PEYRONIE病 动物模型 Peyronie's disease animal model
  • 相关文献

参考文献2

二级参考文献28

  • 1Muller A, Mulhall JP. Peyronie's disease intervention trials: Methodological challenges and issues. J Sex Med, 2009, 6 (3) : 848-861.
  • 2Ralph D, Gonzalez-Cadavid N, Mirone V, et al. The management of Peyronie's disease: Evidence-based 2010 guidelines . J Sex Med, 2010, 7(7) : 2359-2374.
  • 3Tal R, Hall MS, Alex B, et al. Peyronie's disease in teenagers. J Sex Med, 2012, 9(1 ): 302-308.
  • 4Paulis G, Brancato T. Inflammatory mechanisms and oxidative stress in Peyronie's disease : Therapeutic" rationale" and related emerging treatment strategies. Inilamm Allergy Drug Targets, 2012, 11(1) : 48-57.
  • 5Del Carlo M, Cole AA, Levine LA. Differential calcium independent regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by interleukin-1 beta and transfor- ming growth factor-beta in Peyronie's plaque fibroblasts. J Urol, 2008, 179(6): 2447-2455.
  • 6Jang JH, Ryu JK, Suh JK. Activin receptor-like kinase 5 inhibi- tor attenuates fibrosis in fibroblasts derived from Peyronie "s plaque. Korean J Urol, 2012, 53(1) : 44-49.
  • 7Nam HJ, Park HJ, Park NC. Does testosterone deficiency exaggerate the clinical symptoms of Peyronie's disease7 Int J Urol, 2011, 18(11) : 796-800.
  • 8Dolmans GH, Werker PM, de Jong I J, et al. WNT2 locus is involved in genetic susceptibility of Peymnie- disease. J Sex Med, 2012, 9(5) : 1430-1434.
  • 9Acikgoz A, Gokce E, Asci R, et al. Relationship between penile fracture and Peyronieg disease: A prospective study. Int J Impot Res, 2011,23(4) : 165-172.
  • 10Chung E, Yah H, De Young L, et al. Penile Doppler sonographic and clinical characteristics in Peyronieg disease and/or erectile dysfunction: An analysis of 1 500 men with male sexual dysfunction. BJU Int, 2012, 110(8) : 1201-1205.

共引文献10

同被引文献7

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部